Form Type: 4

SEC EDGAR Link
Accession Number:0000899243-21-028185
Date:2021-07-08
Issuer: RECRO PHARMA, INC. (REPH)
Original Submission Date:

Reporting Person:

LAKE RYAN DAVID
C/O RECRO PHARMA, INC.
1 E. UWCHLAN AVE, SUITE 112 EXTON, PA 19341

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2021-07-08 F 5,172 d $1.96 373,173 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 shares were withheld by the issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.

Elevate your investments